The concept behind gene therapy is simple: deliver a healthy gene to compensate for one that is mutated. New research published today in the
Journal of Neuroscience suggests this approach may eventually be a feasible option to treat Rett Syndrome, the most disabling of the autism spectrum disorders. Gail Mandel, Ph.D., a Howard Hughes Investigator at Oregon Health and Sciences University, led the study. The Rett Syndrome Research Trust, with generous support from the Rett Syndrome Research Tr...
Continue reading...
Posted by Fridrik Fridriksson.